Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aclaris Therapeutics

1.56
+0.03001.96%
Post-market: 1.53-0.0300-1.92%19:15 EDT
Volume:666.22K
Turnover:1.02M
Market Cap:168.92M
PE:-1.08
High:1.56
Open:1.53
Low:1.50
Close:1.53
Loading ...
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Correspondence

Form CORRESP - Correspondence
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 27, 2024

Correspondence

Form CORRESP - Correspondence
Nov 27, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 25, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 21, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Oct 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]